Skip to main content

Table 4 The relative expression of the target proteins in the control, cisplatin, and 0.64 mg/mL SPS groups

From: Safflower polysaccharide inhibits the development of tongue squamous cell carcinoma

Groups

Bcl-2

COX-2

Bax

Cleaved caspase-3

Control (24 h)

0.723 ± 0.121

0.918 ± 0.095

0.282 ± 0.164

0.464 ± 0.091

Control (48 h)

0.719 ± 0.196

0.922 ± 0.132

0.283 ± 0.053

0.460 ± 0.021

Control (72 h)

0.733 ± 0.198

0.899 ± 0.210

0.290 ± 0.026

0.465 ± 0.018

Cisplatin (24 h)

0.442 ± 0.113*

0.661 ± 0.066*

0676 ± 0.103*

0.679 ± 0.093*

Cisplatin (48 h)

0.393 ± 0.045*

0.458 ± 0.072*

0.867 ± 0.064*

0.863 ± 0.123*

Cisplatin (72 h)

0.107 ± 0.062

0.237 ± 0.069

0.916 ± 0.093*

0.991 ± 0.133*

SPS (24 h)

0.513 ± 0.101*

0.795 ± 0.135*

0.740 ± 0.0858

0.602 ± 0.076*

SPS (48 h)

0.392 ± 0.083*

0.590 ± 0.099*

0.920 ± 0.083*

0.764 ± 0.063*

SPS (72 h)

0.206 ± 0.106*

0.435 ± 0.021*

1.832 ± 0.925*

0.948 ± 0.089*

  1. SPS safflower polysaccharide. *P < 0.05 compared with the control group